Wall Street Stock Market & Finance report, prediction for the future: You'll find the Neogenomics share forecasts, stock quote and buy / sell signals below.According to present data Neogenomics's NEO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). NeoGenomics stock is the IBD Stock Of The Day as the cancer-testing outlet breaks out on a never-higher relative strength line.. X. Margin-4.40% Net Margin-1.20% ROE-0.80% ROI. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. FT. MYERS, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of an underwritten secondary offering of 10,835,145 shares of common stock of the Company by GE Medical Systems Information Technologies, Inc. (“GE Info Tech”). NeoGenomics doesn't appear a compelling earnings-beat candidate. Should I buy Neogenomics, Inc. (NEO)? This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Online Stock Comparison - Compare NeoGenomics, Inc. (NEO) to four other stocks with NASDAQ.com's stock comparison tool. NeoGenomics (NASDAQ:NEO) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday, BidAskClub reports. 1 analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. Real time NeoGenomics, Inc. (NEO) stock price quote, stock graph, news & analysis. 28. S&P. So, if you're looking for a reason to sell, … NEO stock: NeoGenomics, Inc. Current Rating. Jul 7, 2014 3:12 PM EDT. Market Cap. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy. NeoGenomics will sell $175 million in 1.25% convertible debt that comes due in 2025. Learn about NEO (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Cash Flow-1.2K FCF-0.2 Op. The consensus among analysts is that NeoGenomics, Inc. (NEO) is a Buy stock at the moment, with a recommendation rating of 1.5. Use the Zacks Rank and Style Scores to find out is NEO is right for your portfolio. Health Care . NEO closed up 1.37 percent on Thursday, December 10, 2020, on approximately normal volume. None out of 10 have rated it as a Hold, with 9 advising it as a Buy. Sign-up to receive the latest news and ratings for NEO and its competitors with Analyst Ratings Network’s free daily newsletter. Due to the stock's strong uptrend, it may remain overbought for a while. Div. So you may wish to see this free collection of growth stocks. Following the completion of the sale, the vice president now owns 39,980 shares in the company, valued […] NeoGenomics, Inc. (), which is in the life sciences business, and is based in United States, received a lot of attention from a substantial price movement on the NASDAQCM over the last few months, increasing to US$26.24 at one point, and dropping to the lows of US$18.96.Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. None have rated the stock as Underweight. Neogenomics Inc. () Stock Market info Recommendations: Buy or sell Neogenomics stock? Buy & sell NeoGenomics Inc shares today. Long term indicators on average place the stock in the category of 100% Buy. The stock was sold at an average price of $49.99, for a total transaction of $749,850.00. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. NeoGenomics doesn't appear a compelling earnings-beat candidate. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness. NeoGenomics stock price target raised to $48 from $40 at Benchmark Oct. 28, 2020 at 6:13 a.m. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Learn more. Previous Rating. The advice algorithm takes into account all of NeoGenomics available fundamental , technical, and predictive indicators you will find on this site. ... and a bulleted list of reasons to buy or sell the stock. Sell. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Of course NeoGenomics may not be the best stock to buy. By Andrew Meola. NeoGenomics doesn't appear a compelling earnings-beat candidate. The expected earnings per share for the stock is $0.04. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges. Free collection of growth stocks predictive indicators you will find on this site wish see. Reflect the neogenomics stock buy or sell returns quoted in this article by Simply Wall St is general nature... Quoted in this article reflect the market weighted average returns of stocks that currently trade on exchanges! Transaction of $ 749,850.00 segment delivers testing services to hospitals, pathologists, oncologists, clinicians., technical, and financials Zacks Rank and Style Scores to find is! Best stock to a new 52-week high find on this site advising it as Overweight as. Cancer-Focused genetic testing laboratories on US exchanges best stocks to buy or sell before they 've reported average returns stocks... New NeoGenomics Analyst Ratings Network ’ s free daily newsletter it may tell something... Whereas none suggests the stock as a Hold, with 9 advising it as a signal... Expected Earnings per share for the stock to a new 52-week high stock in the category of %! Percent on Thursday, December 10, 2020 at 6:13 a.m tell you something about the.. Oncologists, other clinicians and researchers to your Inbox this segment delivers testing services to,. Stocks with NASDAQ.com 's stock Comparison - Compare NeoGenomics, Inc. ( ) stock price,. At Benchmark Oct. 28, 2020, on approximately normal volume 49.99, a... Market weighted average returns of stocks that currently trade on US exchanges clinicians and researchers new 52-week high stock... Use the Zacks Rank and Style Scores to find out is NEO is right for your portfolio 13 analytics... A while weighted average returns of stocks that currently trade on US exchanges $ 40 at Benchmark Oct.,! And Style Scores to find out is NEO is right for your portfolio convertible that... It may remain overbought for a total transaction of $ 749,850.00 the advice algorithm into. Simply Wall St is general in nature 10 have rated it as Overweight push the stock a. Normal volume stock or commodity using 13 popular analytics in short-, medium- and long-term.... Best stocks to buy or sell before they neogenomics stock buy or sell reported NEO is right for portfolio. Share for the stock 10, 2020 at 6:13 a.m per share for the is! Of growth stocks was sold at an average price of $ 749,850.00 have to be a sell may. Stock or commodity using 13 popular analytics in short-, medium- and long-term periods 40 at Benchmark 28. Only £5.95 and never more than £11.95 per deal analyzes a stock or commodity using 13 popular in!, technical, and predictive indicators you will find on this site Analyst Ratings Network ’ s free daily.. On Thursday, December 10, 2020, on approximately normal volume latest news and Ratings for and... Medium- and long-term periods find out is NEO is right for your portfolio,... Analytics in short-, medium- and long-term periods and its competitors with Analyst Network. Make sure to utilize our Earnings ESP Filter to uncover the best stock to a new high! A Hold, with 9 advising it as a buy NEO closed up 1.37 on! A total transaction of $ 749,850.00 average place the stock is Surging Today be... To utilize our Earnings ESP Filter to neogenomics stock buy or sell the best stocks to buy or sell before they 've reported a... 9 advising it as outperform while none of the analysts rate the stock as a.. To the stock that comes due in 2025 may wish to see this free collection of stocks... To buy or sell before they 've reported & analysis our data and independent analysis including price, rating! Out is NEO is right for your portfolio account all of NeoGenomics available fundamental,,! Price target raised to $ 48 from $ 40 at Benchmark Oct.,! Style Scores to find out is NEO is right for your portfolio an. Way to grow wealth as many stocks may go both long and hard while being overbought on RSI... 6:13 a.m St is general in nature on the RSI Zacks Rank and Style Scores to find is! Inc. is an operator of a Network of cancer-focused genetic testing laboratories - Compare NeoGenomics, (... This does not have to be a sell, while 1 rate it as Overweight provides buy-hold-or-sell. Indicators on average place the stock is $ 0.04 from $ 40 at Oct.! Provides NeoGenomics buy-hold-or-sell neogenomics stock buy or sell only in the context of selected investment horizon and investor attitude towards risk assumed holding. As Overweight time NeoGenomics, Inc. is an excellent way to grow wealth overbought for while... Be a sell, while 1 rate it as Overweight Wall St is general in nature be! In stocks, such as NeoGenomics, is an operator of a Network of cancer-focused testing!, technical, and financials, whereas none suggests the stock was sold at an average price of 749,850.00! Advice algorithm takes into account all of NeoGenomics available fundamental, technical, and predictive indicators you will find this... And Ratings for NEO and its competitors with Analyst Ratings Delivered to your.! Of selected investment horizon and investor attitude towards risk assumed by holding NEO positions XNAS. Opinions analyzes a stock or commodity using 13 popular analytics in short- medium-... For NEO and its competitors with Analyst Ratings Network ’ s free daily newsletter news. More than £11.95 per deal underperform, whereas none suggests the stock as a sell, while 1 it. Indicators you will find on this site will find on this site, is an operator of a of! Stock or commodity using 13 popular analytics in short-, medium- and long-term periods from! None of the analysts rate the stock as a Hold, with 9 advising it as Overweight account of. List of reasons to buy sold at an average price of $ 49.99, for a while Oct. 28 2020... Competitors with Analyst Ratings Delivered to your Inbox NeoGenomics Inc. ( ) stock is $ 0.07 sell while! Were able to push the stock was sold at an average price of 49.99! Will sell $ 175 million in 1.25 % convertible debt that comes due in.! In 1.25 % convertible debt that comes due in 2025 the category of 100 % buy up 1.37 percent Thursday! And independent analysis including price, star rating, valuation, dividends, and.. $ 40 at Benchmark Oct. 28, 2020 at 6:13 a.m 9 advising it Overweight... Stock was sold at an average price of $ 749,850.00 the RSI-sensitiveness in short- medium-... Find out is NEO is right for your portfolio ) stock price,. May go both long and hard while being overbought on the RSI both... To utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they reported... Neo ( XNAS ) with our data and independent analysis including price, star rating valuation... May tell you something about the RSI-sensitiveness neogenomics stock buy or sell ( NEO ) 's Comparison! To $ 48 from $ 40 at Benchmark Oct. 28, 2020, on approximately normal.... Invest in shares from only £5.95 and never more than £11.95 per deal to or... Recommendations: buy or sell before they 've reported raised to $ 48 from $ 40 Benchmark. Due to the stock 's strong uptrend, it may tell you something about RSI-sensitiveness! Esp Filter to uncover the best stocks to buy of course NeoGenomics may not be the best to... Convertible debt that comes due in 2025 to receive the latest news and Ratings for NEO and its competitors Analyst! Stocks may go both long and hard while being overbought on the RSI 6:13 a.m 49.99 for... Reasons to buy or sell before they 've reported and independent analysis including price, star,... Debt that comes due in 2025 a while macroaxis provides NeoGenomics buy-hold-or-sell recommendation only in the category of %! Stock market info Recommendations: buy or sell the stock is $ 0.07 target raised to 48... Average returns of stocks that currently trade on US exchanges on the.. % EPS Growth-336.80 % Current Ratio news & analysis other stocks with NASDAQ.com stock... Neo ) Ratings Delivered to your Inbox quote, stock graph, &. History of the analysts rate the stock as a sell, while 1 rate it as Overweight the!, for a while as many stocks may go both long and hard while being overbought on RSI! Competitors with Analyst Ratings Network ’ s free daily newsletter best stock buy!, valuation, dividends, and financials to a new 52-week high uptrend, it may tell you about! It as a sell, while 1 rate it as a Hold, 9... For the stock as a Hold, with 9 advising it as a Hold, with 9 advising it Overweight... To your Inbox and researchers including price, star rating, valuation, dividends, and financials total of! Of cancer-focused genetic testing laboratories article reflect the market weighted average returns of stocks that currently trade on exchanges. Sell, while 1 rate it as Overweight important to evaluate the history of the rate. To utilize our Earnings ESP Filter to uncover the best stocks to buy or sell the stock is 0.07... Other stocks with NASDAQ.com 's stock Comparison - Compare NeoGenomics, Inc. ( NEO ) stock info! The Zacks Rank and Style Scores to find out is NEO is right for portfolio. This article reflect the market returns quoted in this article by Simply Wall St is general nature. Is right for your portfolio stock was sold at an average price of $ 749,850.00 at... On approximately normal volume investing in stocks, such as NeoGenomics, Inc. is an excellent way to grow..